Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis

References

• Cassidy JT, Petty RE. Chronic arthritis, poly arthritis, oligoar-thritis, systemic arthritis. In: Cassidy JT, Petty RE, Laxer RM, Linsley CB, editors. Textbook of pediatric rheumatology. 5th ed. Philadelphia: Elsevier Saunders; 2005. p. 206–303.
   Google Scholar
• Fink CW. Proposal for the development of classification criteria for the idiopathic arthritides of childhood. J Rheumatol. 1995;22: 1566–9.
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991–4.
   PubMedGoogle Scholar
• Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M. Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis. Mod Rheumatol. 2004;14:12–7.
   PubMedGoogle Scholar
• Ramanan AV, Grom AA. Does systemic-onset juvenile idio-pathic arthritis belong under juvenile idiopathic arthritis? Rheu-matology. 2005;44:1350-3.
   Google Scholar
• Lovell DJ. Update on treatment of arthritis in children-new treatment, new goals. Bull Hosp Jt Dis. 2006;64:72–6.
   Google Scholar
• Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008; 371:998–1006.
   PubMed Web of Science ®Google Scholar
• Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile idiopathic arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342:763–9.
   PubMed Web of Science ®Google Scholar
• van Rossum MA, Zwinderman AH, Boers M, Dijkmans BA, van Soesbrqen RM, Fiselier TJ, et al. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a stan-dardized assessment method. Arthritis Rheum. 2003;48:507–15.
   PubMed Web of Science ®Google Scholar
• Pozanski AK, Hernandez RJ, Guire KE, Bereza VL, Gam SM. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syn-dromes. Radiology. 1978;129:661–8.
   Google Scholar
• Inamo Y, Harada K. Normal range of carpal length in Japanese children. Nihon Univ J Med. 1998;40:81–7.
   Google Scholar
• Nishiyama S, Kiwaki K, Inomoto T, Seino Y. Bone mineral density of the lumbar spine and total body mass in Japanese children and adolescents. J Jpn Pediatr Soc. 1999;103:1131–8.
   Google Scholar
• Steinbrocker 0, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659–62.
   PubMed Web of Science ®Google Scholar
• Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 1971;14:706–20.
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh). 1977;18:481–91.
   Google Scholar
• van der Heijge D, Dnakert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of simplification of the Sharp/van der Heijge radiological assessment in rheumatoid arthritis. J Rheumatol. 1999;38:941–7.
   Google Scholar
• Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis. 2002;61:84–6.
   Google Scholar
• Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor KB ligand/osteoclast differentiation factor in osteoclasto-genesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:259–69.
   PubMed Web of Science ®Google Scholar
• Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology. 2001;40: 623–30.
   PubMed Web of Science ®Google Scholar
• Pettit AR, Walsh NC, Manning C, Goldrinq SR, Gravallese EM. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology. 2006;45:1068–76.
   Google Scholar
• Varsani H, Patel A, van Kooyk Y, Woo P, Wedderbum LR. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-KB (RANK). Rheumatology. 2003;42:583–90.
   Google Scholar
• Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, et al. Osteoprotegerin (OPG)/RANK-L system in juvenile idio-pathic arthritis: is there a potential modulating role for OPG/ RANK-1 in bone injury? J Rheumatol. 2004;31: 986–91.
   Google Scholar
• Sarma PK, Misra R, Aqqarwal A. Elevated serum receptor acti-vator of NF-KB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2008;27: 289–94.
   Google Scholar
• Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J Rheumatol. 2006;33:1642–5.
   PubMedGoogle Scholar
• Okumus 0, Erguven M, Deveci M, Yilmaz 0, Okumus M. Growth and bone mineralization in patients with juvenile idio-pathic arthritis. Indian J Pediatr. 2008;75:239–43.
   Google Scholar
• Henderson CJ, Cawkwell GD, Specker BL, Sierra RI, Wilmott RW, Campaiqne BN, et al. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:1967–75.
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Specker BL, Sierra RI, Campaiqne BN, Lovell DJ. Total-body bone mineral content in non-corticosteroid treated postpubertal females with juvenile rheumatoid arthritis: fre-quency of osteopenia and contributing factors. Arthritis Rheum. 2000;43:531–40.
   Google Scholar
• Hartman C, Shamir R, Eshach-Adiv 0, losilevsky G, Brik R. Assessment of osteoporosis by quantitative ultrasound versus dual energy X-ray absorptiometry in children with chronic rheumatic disease. J Rheumatol. 2004;31:981–5.
   Google Scholar
• De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006;54: 3551–63.
   PubMed Web of Science ®Google Scholar